Wuxi AppTec distributes 5.7 billion yuan in dividends! Aiming for 50 billion yuan in revenue by 2026, investing real cash to counter market turbulence

WuXi AppTec (603259.SH/2359.HK) is building certainty in a volatile market with record-breaking shareholder returns and ambitious growth targets. Based on an outstanding performance with net profit attributable to shareholders expected to surge 102.65% year-over-year to 19.151 billion yuan by 2025, the company will distribute a total cash dividend of over 5.7 billion yuan for 2025, in line with its consistent approximately 30% dividend policy. Additionally, with a scheduled mid-year dividend for 2026, the total dividend for 2026 will set a new record since the company’s listing. Meanwhile, with nearly 58 billion yuan in on-hand orders and a clear growth trajectory, the company demonstrates strong momentum toward achieving 50 billion yuan in revenue by 2026, adopting a “high return + high growth” strategy to face market challenges.

Supporting this confidence is an impeccable 2025 performance report: the company’s full-year revenue is projected to reach 45.456 billion yuan, setting a new record; even the core business profit quality reflected by adjusted Non-IFRS net profit attributable to shareholders has achieved a high growth of 41.33%. More importantly, the company’s adjusted operating cash flow for the year increased by 39% year-over-year, providing a solid foundation for continuous and substantial shareholder returns. Over the past seven years, WuXi AppTec has returned over 20 billion yuan to investors through dividends and share repurchases, establishing a stable high-return mechanism as a core feature.

In an external environment full of uncertainties, WuXi AppTec is reinforcing market confidence with two “weapons”: first, tangible immediate returns—57 billion yuan in dividends directly boost shareholder income and enhance investment appeal; second, clear and foreseeable endogenous growth—58 billion yuan in orders and global capacity deployment provide high visibility for reaching 50 billion yuan in revenue. Furthermore, with the full-year operational targets announced, a tiered H-share equity incentive plan linked to performance has been implemented simultaneously, deeply aligning core talent interests with the company’s long-term value, thus strengthening the talent foundation for sustained growth.

WuXi AppTec’s actions send a clear signal: in turbulent markets, true resilience comes from solid performance, generous sharing mechanisms, and clear future growth plans. The company is elevating financial returns into a comprehensive commitment to shareholders, employees, and the industry through the implementation of “real cash” and “strategic ambition,” continuously reinforcing its leading position and long-term responsibility as a core infrastructure provider in pharmaceutical R&D.